SIPONIMOD

SIPONIMOD was reported 8919 times

SIPONIMOD is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CSF OLIGOCLONAL BAND 2 0.1818
1 GAIT SPASTIC 50 0.1458
2 CD19 LYMPHOCYTE COUNT ABNORMAL 2 0.0952
3 CSF IMMUNOGLOBULIN INCREASED 3 0.0732
4 NEEDLE FATIGUE 32 0.0700
5 ANAL CYST 4 0.0690
6 RELAPSING-REMITTING MULTIPLE SCLEROSIS 55 0.0637
7 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 77 0.0617
8 EXPANDED DISABILITY STATUS SCALE 4 0.0533
9 MULTIPLE SCLEROSIS PSEUDO RELAPSE 13 0.0383
10 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 69 0.0367
11 SPINAL CORD INJURY THORACIC 3 0.0357
12 LIPIDS DECREASED 3 0.0323
13 DYSMETRIA 16 0.0265
14 DRUG DOSE TITRATION NOT PERFORMED 44 0.0240
15 LYMPHOCYTE COUNT DECREASED 421 0.0238
16 CSF OLIGOCLONAL BAND PRESENT 3 0.0231
17 LYMPHOCYTE COUNT ABNORMAL 24 0.0213
18 GENERAL PHYSICAL CONDITION DECREASED 4 0.0211
19 MONOPARESIS 37 0.0204
20 RELAPSING MULTIPLE SCLEROSIS 6 0.0199
21 DRUG TITRATION ERROR 48 0.0186
22 LYMPHOPENIA 227 0.0160
23 HYPERTONIC BLADDER 44 0.0152
24 BANDAEMIA 2 0.0136
25 BAND SENSATION 16 0.0126
26 MACULAR OEDEMA 68 0.0121
27 JC POLYOMAVIRUS TEST POSITIVE 13 0.0111
28 MULTIPLE SCLEROSIS 489 0.0102
29 PARAPARESIS 18 0.0101
30 PARESIS 22 0.0099
31 OBSTRUCTIVE SLEEP APNOEA SYNDROME 14 0.0096
32 DRUG MONITORING PROCEDURE NOT PERFORMED 17 0.0095
33 TRIGEMINAL NEURALGIA 37 0.0092
34 CENTRAL VISION LOSS 2 0.0090
35 URINARY TRACT INFLAMMATION 3 0.0083
36 MULTIPLE SCLEROSIS RELAPSE 548 0.0080
37 MUSCLE SPASTICITY 98 0.0080
38 CENTRAL NERVOUS SYSTEM LESION 107 0.0078
39 MELANOCYTIC NAEVUS 34 0.0077
40 HEAT ILLNESS 5 0.0074
41 ATRIOVENTRICULAR BLOCK FIRST DEGREE 32 0.0074
42 HEART RATE DECREASED 244 0.0069
43 CORONAVIRUS TEST POSITIVE 7 0.0068
44 RECTAL ADENOCARCINOMA 4 0.0066
45 BASAL CELL CARCINOMA 102 0.0065
46 CONCOMITANT DISEASE AGGRAVATED 40 0.0065
47 SARS-COV-2 ANTIBODY TEST NEGATIVE 3 0.0063
48 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS 3 0.0062
49 ELECTRIC SHOCK SENSATION 17 0.0061
50 T-LYMPHOCYTE COUNT DECREASED 4 0.0059
51 MAGNETIC RESONANCE IMAGING ABNORMAL 7 0.0059
52 OPHTHALMIC MIGRAINE 4 0.0058
53 PERONEAL NERVE PALSY 32 0.0056
54 JC VIRUS INFECTION 9 0.0056
55 OPTIC NEURITIS 51 0.0056
56 NONINFECTIVE ENCEPHALITIS 4 0.0056
57 HYPERTENSIVE URGENCY 3 0.0054
58 NEUROGENIC BLADDER 11 0.0052
59 FINE MOTOR SKILL DYSFUNCTION 15 0.0052
60 CONGENITAL DIAPHRAGMATIC HERNIA 2 0.0051
61 SPINAL EPIDURAL HAEMATOMA 3 0.0051
62 AMBLYOPIA 3 0.0051
63 CATARACT SUBCAPSULAR 3 0.0049
64 COSTOCHONDRITIS 8 0.0049
65 ACOUSTIC NEUROMA 2 0.0049
66 POST HERPETIC NEURALGIA 7 0.0049
67 EXCESSIVE CERUMEN PRODUCTION 3 0.0048
68 CHALAZION 3 0.0047
69 HEMIPARESIS 79 0.0047
70 MICTURITION URGENCY 53 0.0046
71 ACROCHORDON 6 0.0045
72 OPHTHALMOPLEGIA 7 0.0044
73 PROGRESSIVE MULTIPLE SCLEROSIS 5 0.0043
74 LIMB DISCOMFORT 133 0.0043
75 CYSTOID MACULAR OEDEMA 8 0.0042
76 ANTIBODY TEST ABNORMAL 3 0.0042
77 DYSGRAPHIA 27 0.0041
78 ATAXIA 48 0.0040
79 BRAIN STEM SYNDROME 3 0.0040
80 HEMIANAESTHESIA 3 0.0038
81 BALANCE DISORDER 319 0.0037
82 PRODUCT SUPPLY ISSUE 26 0.0036
83 GLIOBLASTOMA MULTIFORME 3 0.0036
84 MOVEMENT DISORDER 113 0.0035
85 OPTIC NERVE INJURY 4 0.0034
86 BLADDER DISORDER 34 0.0034
87 HYPOKINESIA 48 0.0033
88 URINE ABNORMALITY 15 0.0033
89 WHITE MATTER LESION 4 0.0032
90 LIVER FUNCTION TEST INCREASED 68 0.0032
91 SOLAR LENTIGO 3 0.0032
92 RETINAL OEDEMA 6 0.0031
93 DECREASED IMMUNE RESPONSIVENESS 30 0.0031
94 TEMPERATURE INTOLERANCE 31 0.0030
95 MONOPLEGIA 13 0.0030
96 NOCTURIA 36 0.0030
97 MOBILITY DECREASED 212 0.0029
98 BLADDER DYSFUNCTION 3 0.0029
99 IMMUNOGLOBULINS DECREASED 4 0.0029
100 BREAST NEOPLASM 3 0.0029
101 SARS-COV-2 TEST POSITIVE 38 0.0029
102 GAIT DISTURBANCE 539 0.0028
103 SQUAMOUS CELL CARCINOMA OF SKIN 17 0.0028
104 NOROVIRUS INFECTION 4 0.0028
105 THROAT CLEARING 10 0.0027
106 DYSARTHRIA 99 0.0026
107 PIGMENTATION DISORDER 16 0.0026
108 LUMBAR RADICULOPATHY 3 0.0026
109 NEOPLASM SKIN 4 0.0026
110 ALLODYNIA 3 0.0026
111 WHITE BLOOD CELL COUNT DECREASED 277 0.0026
112 DIPLEGIA 5 0.0025
113 OCULAR DISCOMFORT 28 0.0025
114 SENSORY LOSS 20 0.0025
115 INCONTINENCE 26 0.0025
116 MALIGNANT MELANOMA IN SITU 3 0.0024
117 CIRCADIAN RHYTHM SLEEP DISORDER 2 0.0024
118 CSF PROTEIN INCREASED 2 0.0024
119 QUADRIPARESIS 4 0.0024
120 BLADDER DISCOMFORT 3 0.0024
121 WALKING DISABILITY 5 0.0024
122 URINE ODOUR ABNORMAL 14 0.0024
123 EYE CONTUSION 5 0.0024
124 EXPOSURE TO SARS-COV-2 4 0.0024
125 LAZINESS 4 0.0023
126 ADENOCARCINOMA PANCREAS 3 0.0023
127 GAIT INABILITY 78 0.0023
128 CORONARY ARTERY DISSECTION 2 0.0023
129 CEREBRAL DISORDER 17 0.0023
130 URINARY TRACT INFECTION 385 0.0023
131 VITREOUS FLOATERS 22 0.0022
132 MEMORY IMPAIRMENT 307 0.0022
133 SQUAMOUS CELL CARCINOMA 21 0.0022
134 PHOTOPSIA 14 0.0022
135 VISUAL IMPAIRMENT 272 0.0022
136 ABSCESS ORAL 3 0.0022
137 MUSCULAR WEAKNESS 247 0.0022
138 DISCHARGE 3 0.0022
139 COGNITIVE DISORDER 101 0.0022
140 MUSCULOSKELETAL DISCOMFORT 37 0.0021
141 SINUS PAIN 5 0.0021
142 BLADDER SPASM 4 0.0021
143 HEPATIC ENZYME INCREASED 145 0.0021
144 URINARY HESITATION 5 0.0021
145 COVID-19 367 0.0021
146 HYPOAESTHESIA 313 0.0021
147 CEREBELLAR ATAXIA 2 0.0021
148 PARAPLEGIA 6 0.0021
149 COLON NEOPLASM 2 0.0021
150 SEBORRHOEIC KERATOSIS 3 0.0021
151 AXILLARY PAIN 3 0.0020
152 HEPATIC ENZYME ABNORMAL 10 0.0020
153 DECUBITUS ULCER 16 0.0020
154 UROSEPSIS 18 0.0019
155 GAMMA-GLUTAMYLTRANSFERASE INCREASED 43 0.0019
156 ANKLE FRACTURE 30 0.0019
157 VISUAL FIELD DEFECT 14 0.0019
158 ACTINIC KERATOSIS 5 0.0019
159 DYSSTASIA 56 0.0019
160 BRAIN FOG 30 0.0019
161 FACIAL PAIN 17 0.0019
162 ANAL INCONTINENCE 17 0.0019
163 DIPLOPIA 49 0.0019
164 OPTIC NERVE DISORDER 3 0.0019
165 CD4 LYMPHOCYTES DECREASED 4 0.0019
166 MATERNAL EXPOSURE TIMING UNSPECIFIED 7 0.0019
167 WEIGHT BEARING DIFFICULTY 5 0.0019
168 BONE NEOPLASM 2 0.0019
169 URINARY INCONTINENCE 55 0.0019
170 CARDIAC FLUTTER 12 0.0019
171 LANGUAGE DISORDER 4 0.0018
172 LOSS OF CONTROL OF LEGS 7 0.0018
173 CLUMSINESS 5 0.0018
174 NEURALGIA 44 0.0018
175 VACCINATION FAILURE 3 0.0018
176 MALIGNANT MELANOMA 24 0.0018
177 CONTRAINDICATED PRODUCT PRESCRIBED 3 0.0018
178 POST PROCEDURAL HAEMATOMA 3 0.0018
179 POLLAKIURIA 74 0.0018
180 LOWER RESPIRATORY TRACT INFECTION 80 0.0018
181 DRUG EFFECT LESS THAN EXPECTED 26 0.0018
182 CENTRAL NERVOUS SYSTEM INFECTION 2 0.0017
183 HYPERTONIA 10 0.0017
184 IMMUNE SYSTEM DISORDER 23 0.0017
185 NEUROLOGICAL DECOMPENSATION 4 0.0017
186 MENINGITIS CRYPTOCOCCAL 3 0.0017
187 BRADYCARDIA 91 0.0017
188 VERTIGO POSITIONAL 3 0.0017
189 GRIP STRENGTH DECREASED 15 0.0017
190 INCOHERENT 11 0.0017
191 VISION BLURRED 230 0.0017
192 SKIN CANCER 36 0.0017
193 SPEECH DISORDER 87 0.0017
194 WRONG DOSE 4 0.0017
195 DISORGANISED SPEECH 3 0.0016
196 BLOOD IRON INCREASED 3 0.0016
197 APHASIA 48 0.0016
198 LEUKOPENIA 79 0.0016
199 PERIPHERAL SWELLING 243 0.0016
200 COORDINATION ABNORMAL 22 0.0016
201 MUSCULOSKELETAL DISORDER 30 0.0016
202 HEMIPLEGIA 13 0.0016
203 FALL 519 0.0016
204 PHYSICAL DECONDITIONING 4 0.0016
205 PRODUCT AVAILABILITY ISSUE 35 0.0015
206 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
207 LYMPHOCYTE COUNT INCREASED 5 0.0015
208 FACIAL PARALYSIS 13 0.0015
209 ENERGY INCREASED 9 0.0015
210 MIGRAINE 145 0.0015
211 NEAR DEATH EXPERIENCE 5 0.0015
212 PRODUCT DISTRIBUTION ISSUE 14 0.0015
213 NYSTAGMUS 8 0.0015
214 WHITE BLOOD CELL DISORDER 4 0.0015
215 BLOOD TEST ABNORMAL 21 0.0015
216 FOAMING AT MOUTH 3 0.0015
217 SUDDEN HEARING LOSS 3 0.0015
218 SKIN ABRASION 7 0.0015
219 NIPPLE PAIN 3 0.0015
220 INVASIVE DUCTAL BREAST CARCINOMA 4 0.0015
221 B-LYMPHOCYTE COUNT DECREASED 2 0.0015
222 HEAD DISCOMFORT 26 0.0015
223 PARALYSIS 21 0.0015
224 CALCULUS BLADDER 2 0.0015
225 DEMYELINATION 6 0.0015
226 CORNEAL ABRASION 2 0.0015
227 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 12 0.0015
228 CHEST INJURY 3 0.0014
229 VARICELLA ZOSTER VIRUS INFECTION 3 0.0014
230 FUNCTIONAL GASTROINTESTINAL DISORDER 5 0.0014
231 HEADACHE 892 0.0014
232 STATUS EPILEPTICUS 16 0.0014
233 APPENDIX DISORDER 2 0.0014
234 MACULOPATHY 5 0.0014
235 LOWER LIMB FRACTURE 27 0.0014
236 PRODUCT DISPENSING ISSUE 6 0.0014
237 ABNORMAL SENSATION IN EYE 6 0.0014
238 FIBULA FRACTURE 4 0.0014
239 SKIN LESION 38 0.0014
240 VITREOUS DETACHMENT 3 0.0014
241 BILIARY COLIC 4 0.0014
242 INFECTION SUSCEPTIBILITY INCREASED 3 0.0014
243 HYPERTENSION 290 0.0014
244 NECK INJURY 4 0.0014
245 CORONAVIRUS INFECTION 9 0.0014
246 STRABISMUS 4 0.0014
247 DIZZINESS 674 0.0013
248 CYSTITIS 43 0.0013
249 PRODUCT DOSE OMISSION ISSUE 396 0.0013
250 DIZZINESS POSTURAL 13 0.0013
251 TRANSIENT ISCHAEMIC ATTACK 45 0.0013
252 PAPILLOEDEMA 6 0.0013
253 MUSCULOSKELETAL STIFFNESS 116 0.0013
254 ERECTILE DYSFUNCTION 34 0.0013
255 EYE DISORDER 43 0.0013
256 BLOOD PRESSURE ABNORMAL 26 0.0013
257 MUSCLE TIGHTNESS 21 0.0013
258 EXTRASYSTOLES 9 0.0013
259 MENOPAUSAL SYMPTOMS 3 0.0013
260 FATIGUE 1002 0.0013
261 TIBIA FRACTURE 6 0.0013
262 BLOOD CREATININE DECREASED 4 0.0013
263 EYE PAIN 72 0.0013
264 VARICELLA 3 0.0013
265 SEIZURE 144 0.0012
266 INTRACRANIAL ANEURYSM 5 0.0012
267 PERIORBITAL SWELLING 7 0.0012
268 VITAMIN D DEFICIENCY 12 0.0012
269 EYE OEDEMA 3 0.0012
270 FEELING ABNORMAL 292 0.0012
271 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
272 IMMUNODEFICIENCY 18 0.0012
273 EYE HAEMORRHAGE 16 0.0012
274 URINARY TRACT INFECTION BACTERIAL 3 0.0012
275 BRADYKINESIA 7 0.0012
276 HERPES ZOSTER 68 0.0012
277 VERTIGO 72 0.0012
278 APPENDICITIS PERFORATED 3 0.0012
279 HEPATIC CYST 4 0.0012
280 MOTOR DYSFUNCTION 12 0.0012
281 POOR PERIPHERAL CIRCULATION 5 0.0012
282 BLADDER NEOPLASM 2 0.0012
283 EYE MOVEMENT DISORDER 8 0.0012
284 PRODUCT TEMPERATURE EXCURSION ISSUE 6 0.0012
285 TEARFULNESS 5 0.0012
286 LYMPHOEDEMA 8 0.0012
287 POSTMENOPAUSAL HAEMORRHAGE 3 0.0011
288 ILLNESS 118 0.0011
289 DYSPHEMIA 5 0.0011
290 BLOOD PRESSURE INCREASED 174 0.0011
291 HEAD INJURY 36 0.0011
292 DEPRESSIVE SYMPTOM 4 0.0011
293 IMMUNOSUPPRESSION 10 0.0011
294 PRODUCT DOSE OMISSION IN ERROR 32 0.0011
295 ANIMAL BITE 3 0.0011
296 RETINAL HAEMORRHAGE 8 0.0011
297 ABDOMINAL MASS 3 0.0011
298 TREMOR 185 0.0011
299 FRUSTRATION TOLERANCE DECREASED 9 0.0011
300 LIGAMENT SPRAIN 11 0.0011
301 NORMAL NEWBORN 6 0.0011
302 PRODUCT DOSE OMISSION 72 0.0011
303 SPONDYLITIS 4 0.0011
304 WHITE BLOOD CELL COUNT ABNORMAL 7 0.0011
305 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
306 BRAIN NEOPLASM 10 0.0011
307 PARAESTHESIA 171 0.0011
308 BODY TEMPERATURE ABNORMAL 2 0.0011
309 NERVE COMPRESSION 10 0.0011
310 PERSONALITY CHANGE 10 0.0011
311 HEART RATE ABNORMAL 6 0.0011
312 ORAL HERPES 21 0.0011
313 TRICHORRHEXIS 3 0.0011
314 ADENOCARCINOMA OF COLON 2 0.0011
315 CEREBRAL THROMBOSIS 3 0.0011
316 FOOT FRACTURE 20 0.0011
317 PANCREATIC CARCINOMA METASTATIC 3 0.0011
318 RESPIRATORY SYMPTOM 3 0.0011
319 SPUTUM DISCOLOURED 10 0.0011
320 URINARY RETENTION 35 0.0010
321 EPILEPSY 32 0.0010
322 BREAST MASS 7 0.0010
323 VITAMIN B12 DECREASED 3 0.0010
324 PYELONEPHRITIS 9 0.0010
325 CONVERSION DISORDER 2 0.0010
326 PULMONARY PAIN 3 0.0010
327 SPINAL CORD COMPRESSION 4 0.0010
328 CONTUSION 98 0.0010
329 HEART RATE IRREGULAR 23 0.0010
330 COVID-19 PNEUMONIA 12 0.0010
331 CEREBRAL ATROPHY 4 0.0010
332 AMNESIA 65 0.0010
333 CARDIAC DISCOMFORT 2 0.0010
334 FUNGAL SKIN INFECTION 4 0.0010
335 ATRIOVENTRICULAR BLOCK SECOND DEGREE 3 0.0010
336 JOINT INJURY 21 0.0010
337 ASTHENIA 369 0.0010
338 CHROMATURIA 22 0.0010
339 CHANGE OF BOWEL HABIT 2 0.0010
340 RIB FRACTURE 20 0.0010
341 BLOOD PRESSURE FLUCTUATION 23 0.0010
342 PHOTOPHOBIA 18 0.0010
343 SENSITIVITY TO WEATHER CHANGE 5 0.0009
344 JOINT DISLOCATION 10 0.0009
345 MUSCLE FATIGUE 4 0.0009
346 ABSCESS LIMB 4 0.0009
347 ANAEMIA MACROCYTIC 2 0.0009
348 OVERWEIGHT 5 0.0009
349 GINGIVITIS 5 0.0009
350 BLOOD PRESSURE SYSTOLIC INCREASED 18 0.0009
351 ACCIDENT 11 0.0009
352 SOMNOLENCE 184 0.0009
353 LISTLESS 3 0.0009
354 SUSPECTED COVID-19 3 0.0009
355 ACCIDENT AT WORK 2 0.0009
356 SKIN INJURY 3 0.0009
357 CONCUSSION 7 0.0009
358 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
359 URINARY TRACT DISORDER 4 0.0009
360 SUPRAVENTRICULAR EXTRASYSTOLES 3 0.0009
361 WRONG PRODUCT ADMINISTERED 6 0.0009
362 TONGUE ULCERATION 3 0.0009
363 LIMB INJURY 24 0.0009
364 PAIN IN EXTREMITY 258 0.0009
365 NEUROLOGICAL SYMPTOM 5 0.0009
366 PERIPHERAL COLDNESS 12 0.0009
367 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
368 THINKING ABNORMAL 16 0.0009
369 BLINDNESS UNILATERAL 12 0.0008
370 VAGINAL INFECTION 4 0.0008
371 ALANINE AMINOTRANSFERASE INCREASED 52 0.0008
372 CONFUSIONAL STATE 136 0.0008
373 MUSCULOSKELETAL CHEST PAIN 13 0.0008
374 CHOLECYSTITIS 10 0.0008
375 EYE INFLAMMATION 8 0.0008
376 ODYNOPHAGIA 5 0.0008
377 BLINDNESS 34 0.0008
378 GLAUCOMA 16 0.0008
379 PRODUCT DISPENSING ERROR 18 0.0008
380 FEELING COLD 23 0.0008
381 CHOKING 16 0.0008
382 PALPITATIONS 96 0.0008
383 VITAMIN D DECREASED 7 0.0008
384 INCORRECT DOSAGE ADMINISTERED 4 0.0008
385 KIDNEY INFECTION 16 0.0008
386 DYSURIA 30 0.0008
387 ABDOMINAL DISCOMFORT 136 0.0008
388 MUSCLE STRAIN 7 0.0008
389 HYPERTENSIVE CRISIS 9 0.0008
390 SCOLIOSIS 5 0.0008
391 UPPER LIMB FRACTURE 16 0.0008
392 EYE INFECTION 9 0.0008
393 MUSCLE ATROPHY 10 0.0008
394 APHONIA 11 0.0008
395 NECK PAIN 44 0.0008
396 FEELING JITTERY 15 0.0008
397 TOOTH ABSCESS 8 0.0008
398 MUSCLE SPASMS 144 0.0008
399 BOWEL MOVEMENT IRREGULARITY 6 0.0008
400 ELECTROCARDIOGRAM QT PROLONGED 28 0.0008
401 CEREBRAL ISCHAEMIA 4 0.0008
402 DEPRESSED MOOD 41 0.0008
403 GASTROENTERITIS VIRAL 14 0.0008
404 OROPHARYNGEAL DISCOMFORT 7 0.0008
405 TRISMUS 4 0.0008
406 VARICOSE VEIN 4 0.0008
407 SKIN NECROSIS 4 0.0008
408 RESTLESS LEGS SYNDROME 14 0.0008
409 CERVIX CARCINOMA 3 0.0008
410 ORAL INFECTION 3 0.0008
411 PARTIAL SEIZURES 4 0.0008
412 PROSTATOMEGALY 3 0.0008
413 RETINAL DETACHMENT 7 0.0008
414 FULL BLOOD COUNT ABNORMAL 8 0.0008
415 WRIST FRACTURE 9 0.0008
416 APPENDICITIS 7 0.0007
417 SKIN MASS 5 0.0007
418 NASOPHARYNGITIS 138 0.0007
419 PRODUCT SIZE ISSUE 4 0.0007
420 OEDEMA PERIPHERAL 90 0.0007
421 GENERAL PHYSICAL HEALTH DETERIORATION 85 0.0007
422 TRIGGER FINGER 3 0.0007
423 CLONUS 2 0.0007
424 HYPOAESTHESIA ORAL 11 0.0007
425 ESCHERICHIA INFECTION 6 0.0007
426 JOINT SWELLING 88 0.0007
427 DEAFNESS UNILATERAL 4 0.0007
428 ENCEPHALITIS 5 0.0007
429 EXTRA DOSE ADMINISTERED 29 0.0007
430 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
431 INFECTION 103 0.0007
432 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
433 TONGUE DISCOMFORT 3 0.0007
434 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
435 AORTIC VALVE INCOMPETENCE 3 0.0007
436 THERMAL BURN 5 0.0007
437 MALAISE 309 0.0007
438 ANGINA PECTORIS 20 0.0007
439 PRODUCT STORAGE ERROR 61 0.0007
440 FULL BLOOD COUNT DECREASED 14 0.0007
441 CELLULITIS 35 0.0007
442 MUSCLE TWITCHING 16 0.0007
443 SCIATICA 11 0.0007
444 SLUGGISHNESS 7 0.0007
445 PANIC ATTACK 25 0.0007
446 SENSORY DISTURBANCE 11 0.0007
447 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
448 CHEST DISCOMFORT 70 0.0007
449 BLINDNESS TRANSIENT 5 0.0007
450 LETHARGY 39 0.0007
451 PSYCHIATRIC SYMPTOM 5 0.0007
452 BLOOD IRON DECREASED 8 0.0007
453 ABDOMINAL PAIN LOWER 17 0.0007
454 HAEMATURIA 23 0.0007
455 MACULAR DEGENERATION 8 0.0007
456 DISTURBANCE IN ATTENTION 36 0.0007
457 BLOOD CHOLESTEROL INCREASED 31 0.0007
458 HYPERSOMNIA 19 0.0007
459 LOCALISED INFECTION 16 0.0007
460 CATARACT 39 0.0007
461 HIP FRACTURE 21 0.0007
462 LOCALISED OEDEMA 3 0.0006
463 LYMPHOMA 10 0.0006
464 EYE SWELLING 24 0.0006
465 LABORATORY TEST ABNORMAL 19 0.0006
466 SKIN LACERATION 7 0.0006
467 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
468 SECRETION DISCHARGE 8 0.0006
469 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
470 BLEPHAROSPASM 4 0.0006
471 BACK PAIN 147 0.0006
472 LIVER DISORDER 28 0.0006
473 VIRAL INFECTION 21 0.0006
474 RENAL CYST 5 0.0006
475 BILE DUCT STONE 2 0.0006
476 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
477 TYPE 2 DIABETES MELLITUS 21 0.0006
478 SINUS BRADYCARDIA 6 0.0006
479 MENTAL IMPAIRMENT 15 0.0006
480 EAR PAIN 12 0.0006
481 SCAB 7 0.0006
482 BURNING SENSATION 43 0.0006
483 ACUTE MYOCARDIAL INFARCTION 18 0.0006
484 ILL-DEFINED DISORDER 37 0.0006
485 WOUND 17 0.0006
486 STAPHYLOCOCCAL SEPSIS 3 0.0006
487 OROPHARYNGEAL PAIN 56 0.0006
488 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 109 0.0006
489 CHEST PAIN 112 0.0006
490 COLON CANCER 9 0.0006
491 MENSTRUAL DISORDER 5 0.0006
492 PRESCRIBED UNDERDOSE 12 0.0006
493 VEIN DISORDER 3 0.0006
494 ANXIETY DISORDER 2 0.0006
495 SPINAL PAIN 7 0.0006
496 NERVOUSNESS 31 0.0006
497 CONJUNCTIVITIS 11 0.0006
498 TOXIC ENCEPHALOPATHY 3 0.0006
499 HEPATIC STEATOSIS 11 0.0006
500 CEREBROVASCULAR ACCIDENT 100 0.0006
501 EUPHORIC MOOD 6 0.0006
502 LIVER FUNCTION TEST ABNORMAL 17 0.0006
503 INFLUENZA 65 0.0006
504 SKIN HYPERPIGMENTATION 5 0.0006
505 APLASIA PURE RED CELL 2 0.0006
506 INSOMNIA 152 0.0006
507 NEPHROLITHIASIS 26 0.0006
508 BREAST PAIN 6 0.0006
509 PAIN 345 0.0006
510 COMPRESSION FRACTURE 3 0.0006
511 CONDITION AGGRAVATED 170 0.0006
512 BREAST CANCER 52 0.0006
513 ANAL ABSCESS 3 0.0006
514 DISORIENTATION 22 0.0006
515 HEART RATE INCREASED 55 0.0006
516 BEHAVIOUR DISORDER 3 0.0006
517 PANIC REACTION 4 0.0006
518 BACK DISORDER 9 0.0006
519 BACK INJURY 6 0.0006
520 FAECES SOFT 4 0.0005
521 CHOLELITHIASIS 18 0.0005
522 INFLUENZA LIKE ILLNESS 45 0.0005
523 CHILLS 64 0.0005
524 TOOTH FRACTURE 6 0.0005
525 PROSTATIC DISORDER 3 0.0005
526 RASH MACULAR 19 0.0005
527 DRY MOUTH 44 0.0005
528 BLOOD PRESSURE DECREASED 36 0.0005
529 BODY TEMPERATURE INCREASED 11 0.0005
530 FEELING DRUNK 4 0.0005
531 SUNBURN 4 0.0005
532 NAUSEA 424 0.0005
533 REBOUND EFFECT 6 0.0005
534 AUTOIMMUNE THYROIDITIS 2 0.0005
535 SEPSIS 59 0.0005
536 PRODUCT PACKAGING ISSUE 5 0.0005
537 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
538 COMMUNICATION DISORDER 2 0.0005
539 CLAVICLE FRACTURE 2 0.0005
540 HERPES VIRUS INFECTION 3 0.0005
541 ANXIETY 148 0.0005
542 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
543 DYSPHAGIA 49 0.0005
544 UVEITIS 7 0.0005
545 DELUSION 8 0.0005
546 ALOPECIA 101 0.0005
547 PELVIC FRACTURE 4 0.0005
548 COUGH 144 0.0005
549 PHARYNGEAL SWELLING 5 0.0005
550 COLD SWEAT 9 0.0005
551 DECREASED INTEREST 3 0.0005
552 THERAPY CHANGE 5 0.0005
553 PYREXIA 175 0.0005
554 PLEURISY 3 0.0005
555 FURUNCLE 4 0.0005
556 ISCHAEMIC STROKE 9 0.0005
557 HALLUCINATION 38 0.0005
558 HOT FLUSH 38 0.0005
559 HYPOTONIA 5 0.0005
560 BRAIN INJURY 5 0.0005
561 BLEPHARITIS 2 0.0005
562 UTERINE CANCER 4 0.0005
563 HEPATITIS B 3 0.0005
564 UPPER RESPIRATORY TRACT INFECTION 23 0.0005
565 PRESYNCOPE 12 0.0005
566 DEPRESSION 112 0.0005
567 DRY THROAT 5 0.0005
568 INTENTIONAL DOSE OMISSION 14 0.0005
569 RED BLOOD CELL COUNT DECREASED 14 0.0005
570 ASPARTATE AMINOTRANSFERASE INCREASED 26 0.0005
571 FEELING HOT 30 0.0005
572 NEUTROPHIL COUNT INCREASED 5 0.0005
573 MENISCUS INJURY 3 0.0005
574 CHOLANGITIS 3 0.0005
575 SPINAL COMPRESSION FRACTURE 4 0.0005
576 ANOSMIA 7 0.0005
577 EMBOLISM 4 0.0005
578 EYE DISCHARGE 5 0.0005
579 NEOPLASM MALIGNANT 32 0.0005
580 PETECHIAE 5 0.0005
581 TINNITUS 22 0.0005
582 SINUSITIS 49 0.0005
583 SENSATION OF FOREIGN BODY 4 0.0005
584 BLOOD URINE PRESENT 9 0.0005
585 RENAL PAIN 5 0.0005
586 FOREIGN BODY SENSATION IN EYES 3 0.0005
587 HYPOACUSIS 20 0.0005
588 ARRHYTHMIA 22 0.0005
589 THERAPY INTERRUPTED 33 0.0005
590 URINE OUTPUT DECREASED 4 0.0005
591 HAND DEFORMITY 6 0.0005
592 NAIL DISORDER 4 0.0005
593 SOMNAMBULISM 3 0.0005
594 SKIN DISCOLOURATION 21 0.0005
595 IMPAIRED HEALING 15 0.0005
596 FOOT DEFORMITY 5 0.0005
597 EAR INFECTION 12 0.0005
598 SPINAL FRACTURE 9 0.0004
599 SWELLING 42 0.0004
600 RHINORRHOEA 29 0.0004
601 HAEMOLYTIC ANAEMIA 4 0.0004
602 SNEEZING 10 0.0004
603 SWELLING FACE 29 0.0004
604 DYSPHONIA 26 0.0004
605 NASAL CONGESTION 26 0.0004
606 DRY EYE 22 0.0004
607 INTERNAL HAEMORRHAGE 5 0.0004
608 ECCHYMOSIS 3 0.0004
609 PNEUMONIA BACTERIAL 4 0.0004
610 RESPIRATION ABNORMAL 3 0.0004
611 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
612 HUNGER 6 0.0004
613 MASS 6 0.0004
614 CARPAL TUNNEL SYNDROME 6 0.0004
615 FLANK PAIN 4 0.0004
616 HYPERSENSITIVITY 79 0.0004
617 BLOOD SODIUM DECREASED 8 0.0004
618 OEDEMA 23 0.0004
619 DYSPNOEA 240 0.0004
620 SEASONAL ALLERGY 6 0.0004
621 PAIN IN JAW 12 0.0004
622 RESPIRATORY TRACT INFECTION 11 0.0004
623 VISUAL ACUITY REDUCED 14 0.0004
624 DISEASE RECURRENCE 20 0.0004
625 SYNCOPE 42 0.0004
626 GASTRITIS 11 0.0004
627 PARAESTHESIA ORAL 6 0.0004
628 TONGUE DISORDER 3 0.0004
629 CANDIDA INFECTION 7 0.0004
630 DRUG INTOLERANCE 40 0.0004
631 MENTAL DISORDER 18 0.0004
632 PRODUCT USE IN UNAPPROVED INDICATION 102 0.0004
633 TREATMENT FAILURE 34 0.0004
634 CONSTIPATION 89 0.0004
635 BLOOD BILIRUBIN INCREASED 11 0.0004
636 SENSITIVE SKIN 3 0.0004
637 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
638 GASTROINTESTINAL DISORDER 36 0.0004
639 ANEURYSM 2 0.0004
640 AGEUSIA 10 0.0004
641 ATRIAL FIBRILLATION 39 0.0004
642 PNEUMONIA ASPIRATION 10 0.0004
643 CARDIAC DISORDER 37 0.0004
644 DYSKINESIA 16 0.0004
645 WEIGHT INCREASED 88 0.0004
646 INITIAL INSOMNIA 4 0.0004
647 ABDOMINAL PAIN UPPER 80 0.0004
648 APHTHOUS ULCER 3 0.0004
649 TOOTHACHE 7 0.0004
650 HAEMATOMA 10 0.0004
651 HYPOTENSION 77 0.0004
652 ACCIDENTAL OVERDOSE 14 0.0004
653 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
654 JOINT STIFFNESS 10 0.0004
655 PRODUCT PRESCRIBING ERROR 9 0.0004
656 ADVERSE REACTION 5 0.0004
657 ATRIAL FLUTTER 3 0.0004
658 HYPOTHYROIDISM 12 0.0004
659 EATING DISORDER 8 0.0004
660 QUALITY OF LIFE DECREASED 5 0.0004
661 POOR QUALITY SLEEP 8 0.0004
662 MUSCLE DISORDER 3 0.0004
663 THERAPY CESSATION 19 0.0004
664 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
665 MENSTRUATION DELAYED 4 0.0004
666 FAECES DISCOLOURED 8 0.0004
667 CEREBRAL INFARCTION 9 0.0004
668 LYMPHADENOPATHY 13 0.0004
669 LOSS OF CONSCIOUSNESS 47 0.0004
670 IMPAIRED GASTRIC EMPTYING 5 0.0004
671 MOOD ALTERED 10 0.0004
672 DECREASED APPETITE 85 0.0004
673 HYPERAESTHESIA 3 0.0004
674 CORONARY ARTERY OCCLUSION 5 0.0004
675 ASTHENOPIA 2 0.0004
676 GASTROINTESTINAL PAIN 4 0.0004
677 PHOTOSENSITIVITY REACTION 6 0.0004
678 EOSINOPHIL COUNT INCREASED 3 0.0004
679 NERVE INJURY 4 0.0004
680 BLOOD UREA INCREASED 6 0.0004
681 ORAL PAIN 8 0.0004
682 SKIN INFECTION 4 0.0004
683 INCORRECT DOSE ADMINISTERED 81 0.0004
684 SLEEP DISORDER 25 0.0004
685 FLUID RETENTION 18 0.0004
686 NERVOUS SYSTEM DISORDER 11 0.0004
687 IMPAIRED DRIVING ABILITY 4 0.0004
688 VOMITING 164 0.0003
689 UNRESPONSIVE TO STIMULI 9 0.0003
690 HEPATIC FUNCTION ABNORMAL 13 0.0003
691 NEOPLASM 4 0.0003
692 DISCOMFORT 21 0.0003
693 DEAFNESS 9 0.0003
694 MUSCULOSKELETAL PAIN 18 0.0003
695 APATHY 5 0.0003
696 SPINAL OSTEOARTHRITIS 3 0.0003
697 ARTHRALGIA 141 0.0003
698 MYOCARDIAL INFARCTION 59 0.0003
699 MATERNAL EXPOSURE DURING PREGNANCY 30 0.0003
700 THIRST 6 0.0003
701 PRODUCTIVE COUGH 16 0.0003
702 ROAD TRAFFIC ACCIDENT 14 0.0003
703 FEAR 9 0.0003
704 MUSCLE RIGIDITY 4 0.0003
705 THERAPY NON-RESPONDER 15 0.0003
706 HEAVY MENSTRUAL BLEEDING 3 0.0003
707 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
708 LACRIMATION INCREASED 10 0.0003
709 GASTROINTESTINAL CARCINOMA 3 0.0003
710 FUNGAL INFECTION 11 0.0003
711 DISEASE PROGRESSION 39 0.0003
712 INFLAMMATION 17 0.0003
713 IRRITABLE BOWEL SYNDROME 7 0.0003
714 PULMONARY EMBOLISM 31 0.0003
715 ABNORMAL DREAMS 9 0.0003
716 LIVER INJURY 8 0.0003
717 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
718 OVARIAN CANCER 3 0.0003
719 DYSPEPSIA 32 0.0003
720 DIVERTICULITIS 9 0.0003
721 PHARYNGITIS 4 0.0003
722 DEMENTIA 9 0.0003
723 BLISTER 18 0.0003
724 DRUG INEFFECTIVE 422 0.0003
725 DIARRHOEA 206 0.0003
726 NEUTROPHIL COUNT DECREASED 13 0.0003
727 FRACTURE 6 0.0003
728 SPINAL DISORDER 3 0.0003
729 PNEUMOTHORAX 5 0.0003
730 HEPATOTOXICITY 7 0.0003
731 AFFECT LABILITY 3 0.0003
732 HYPERCHOLESTEROLAEMIA 3 0.0003
733 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
734 SKIN ULCER 8 0.0003
735 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22 0.0003
736 DEEP VEIN THROMBOSIS 20 0.0003
737 BRADYPHRENIA 2 0.0003
738 PNEUMONIA 99 0.0003
739 BODY TEMPERATURE DECREASED 3 0.0003
740 MANIA 5 0.0003
741 ORAL CANDIDIASIS 4 0.0003
742 TOOTH INFECTION 4 0.0003
743 HAEMATOCRIT DECREASED 6 0.0003
744 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
745 APPETITE DISORDER 2 0.0003
746 RASH 129 0.0003
747 TASTE DISORDER 6 0.0003
748 PNEUMONITIS 8 0.0003
749 CIRCULATORY COLLAPSE 5 0.0003
750 BLOOD TESTOSTERONE DECREASED 2 0.0003
751 SCAR 5 0.0003
752 ERYTHEMA 60 0.0003
753 INTESTINAL OBSTRUCTION 11 0.0003
754 FEMUR FRACTURE 9 0.0003
755 ADVERSE DRUG REACTION 26 0.0003
756 NIGHTMARE 10 0.0003
757 TENDERNESS 3 0.0003
758 ORAL DISCOMFORT 4 0.0003
759 WEIGHT DECREASED 80 0.0003
760 OXYGEN SATURATION DECREASED 16 0.0003
761 HALLUCINATION, VISUAL 6 0.0003
762 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
763 DECREASED ACTIVITY 3 0.0003
764 HYPERTHYROIDISM 4 0.0003
765 OESOPHAGITIS 3 0.0003
766 GASTROENTERITIS 4 0.0003
767 HYPERHIDROSIS 35 0.0003
768 PULMONARY MASS 4 0.0003
769 BACTERIAL INFECTION 5 0.0003
770 THROAT IRRITATION 12 0.0003
771 INTESTINAL PERFORATION 3 0.0003
772 MITRAL VALVE INCOMPETENCE 3 0.0003
773 AORTIC ANEURYSM 2 0.0003
774 SLEEP APNOEA SYNDROME 5 0.0003
775 INCREASED APPETITE 5 0.0003
776 THROMBOSIS 21 0.0003
777 PRODUCT USE ISSUE 49 0.0003
778 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
779 THYROID DISORDER 4 0.0003
780 EMOTIONAL DISORDER 8 0.0003
781 ATRIOVENTRICULAR BLOCK 2 0.0003
782 HERNIA 5 0.0003
783 AFFECTIVE DISORDER 2 0.0003
784 SINUS DISORDER 5 0.0003
785 PROCEDURAL PAIN 7 0.0003
786 ARTHROPATHY 14 0.0003
787 HALLUCINATION, AUDITORY 4 0.0003
788 ULCER 4 0.0003
789 CEREBRAL HAEMORRHAGE 9 0.0003
790 ABSCESS 4 0.0003
791 BLOOD DISORDER 2 0.0002
792 DIABETES MELLITUS 19 0.0002
793 CRYING 9 0.0002
794 BURSITIS 3 0.0002
795 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 50 0.0002
796 CARDIOMEGALY 3 0.0002
797 LUNG NEOPLASM MALIGNANT 10 0.0002
798 CYST 3 0.0002
799 ACUTE CORONARY SYNDROME 2 0.0002
800 ABDOMINAL DISTENSION 25 0.0002
801 BRAIN OEDEMA 3 0.0002
802 PSYCHOTIC DISORDER 7 0.0002
803 FLUSHING 24 0.0002
804 MYALGIA 40 0.0002
805 INTRAOCULAR PRESSURE INCREASED 3 0.0002
806 GASTRIC DISORDER 8 0.0002
807 BLOOD POTASSIUM DECREASED 7 0.0002
808 ABDOMINAL PAIN 54 0.0002
809 NEUROPATHY PERIPHERAL 22 0.0002
810 CARDIAC MURMUR 2 0.0002
811 DELIRIUM 8 0.0002
812 RASH ERYTHEMATOUS 11 0.0002
813 BRONCHITIS 17 0.0002
814 ARTHRITIS 18 0.0002
815 PULMONARY CONGESTION 3 0.0002
816 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
817 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
818 DRUG-INDUCED LIVER INJURY 7 0.0002
819 DRUG INTERACTION 35 0.0002
820 RESTLESSNESS 8 0.0002
821 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
822 PRURITUS 83 0.0002
823 ARTERIOSCLEROSIS 2 0.0002
824 OSTEOARTHRITIS 9 0.0002
825 LIP SWELLING 7 0.0002
826 SKIN DISORDER 7 0.0002
827 DRY SKIN 28 0.0002
828 SUBDURAL HAEMATOMA 3 0.0002
829 EYE PRURITUS 7 0.0002
830 MYELODYSPLASTIC SYNDROME 3 0.0002
831 ANGER 7 0.0002
832 FIBROMYALGIA 5 0.0002
833 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
834 RESPIRATORY DISORDER 6 0.0002
835 ABORTION SPONTANEOUS 8 0.0002
836 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
837 INTENTIONAL SELF-INJURY 4 0.0002
838 PRODUCT ADMINISTRATION ERROR 4 0.0002
839 HAEMATEMESIS 5 0.0002
840 FEEDING DISORDER 4 0.0002
841 OSTEOPOROSIS 8 0.0002
842 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 10 0.0002
843 ECZEMA 10 0.0002
844 AGITATION 14 0.0002
845 RESPIRATORY TRACT CONGESTION 3 0.0002
846 MOOD SWINGS 6 0.0002
847 DYSPNOEA EXERTIONAL 7 0.0002
848 JAUNDICE 5 0.0002
849 COLITIS 7 0.0002
850 BIPOLAR DISORDER 2 0.0002
851 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
852 BLOOD GLUCOSE FLUCTUATION 2 0.0002
853 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
854 TRANSAMINASES INCREASED 4 0.0002
855 CARDIAC FAILURE 14 0.0002
856 PARANOIA 3 0.0002
857 SHOCK 4 0.0002
858 ORTHOSTATIC HYPOTENSION 3 0.0002
859 RENAL DISORDER 8 0.0002
860 BONE PAIN 10 0.0002
861 METASTASES TO LIVER 3 0.0002
862 TACHYCARDIA 15 0.0002
863 OCULAR HYPERAEMIA 8 0.0002
864 GALLBLADDER DISORDER 3 0.0002
865 URTICARIA 28 0.0002
866 OSTEOMYELITIS 3 0.0002
867 CORONARY ARTERY DISEASE 5 0.0002
868 RESPIRATORY FAILURE 12 0.0002
869 DEATH 138 0.0002
870 GASTRIC CANCER 4 0.0002
871 EYE IRRITATION 9 0.0002
872 HEPATITIS 4 0.0002
873 ERUCTATION 3 0.0002
874 SEDATION 4 0.0002
875 BEDRIDDEN 2 0.0002
876 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
877 ABNORMAL BEHAVIOUR 6 0.0002
878 PANCREATITIS 8 0.0002
879 MENSTRUATION IRREGULAR 4 0.0001
880 GASTROOESOPHAGEAL REFLUX DISEASE 12 0.0001
881 PRODUCT PHYSICAL ISSUE 3 0.0001
882 SUICIDE ATTEMPT 9 0.0001
883 DYSGEUSIA 11 0.0001
884 NEUTROPENIA 20 0.0001
885 COMA 7 0.0001
886 HAEMATOCHEZIA 8 0.0001
887 TOOTH LOSS 3 0.0001
888 MENTAL STATUS CHANGES 4 0.0001
889 HAEMOPTYSIS 4 0.0001
890 DERMATITIS 3 0.0001
891 RENAL IMPAIRMENT 12 0.0001
892 MOUTH ULCERATION 3 0.0001
893 SUICIDAL IDEATION 13 0.0001
894 HYPOXIA 5 0.0001
895 RETCHING 3 0.0001
896 IMPAIRED WORK ABILITY 3 0.0001
897 PANCREATIC CARCINOMA 4 0.0001
898 PROSTATE CANCER 11 0.0001
899 CARDIOMYOPATHY 2 0.0001
900 TOOTH DISORDER 3 0.0001
901 RASH PAPULAR 3 0.0001
902 IRRITABILITY 8 0.0001
903 ANAEMIA 25 0.0001
904 PERICARDIAL EFFUSION 3 0.0001
905 DEHYDRATION 17 0.0001
906 CYANOSIS 2 0.0001
907 NIGHT SWEATS 4 0.0001
908 BLOOD POTASSIUM INCREASED 2 0.0001
909 LUNG DISORDER 6 0.0001
910 ENCEPHALOPATHY 3 0.0001
911 EPISTAXIS 9 0.0001
912 WITHDRAWAL SYNDROME 5 0.0001
913 UNEVALUABLE EVENT 9 0.0001
914 ACNE 9 0.0001
915 SKIN EXFOLIATION 10 0.0001
916 DRUG RESISTANCE 3 0.0001
917 ASTHMA 13 0.0001
918 SEPTIC SHOCK 5 0.0001
919 AMENORRHOEA 2 0.0001
920 INJURY 8 0.0001
921 BREAST CANCER FEMALE 3 0.0001
922 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
923 THROAT TIGHTNESS 3 0.0001
924 PALLOR 3 0.0001
925 C-REACTIVE PROTEIN INCREASED 4 0.0001
926 BONE DISORDER 2 0.0001
927 BLOOD GLUCOSE ABNORMAL 2 0.0001
928 MEDICATION ERROR 6 0.0001
929 OFF LABEL USE 93 0.0001
930 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
931 FLATULENCE 6 0.0001
932 CHOLESTASIS 2 0.0001
933 ACUTE RESPIRATORY FAILURE 2 0.0001
934 PLATELET COUNT DECREASED 11 0.0001
935 NEEDLE ISSUE 3 0.0001
936 PLASMA CELL MYELOMA 4 0.0001
937 AGGRESSION 5 0.0001
938 PLEURAL EFFUSION 6 0.0001
939 SKIN BURNING SENSATION 7 0.0001
940 ADVERSE EVENT 9 0.0001
941 HAEMOGLOBIN DECREASED 10 0.0001
942 SWOLLEN TONGUE 3 0.0001
943 BONE DENSITY DECREASED 3 0.0001
944 HAEMORRHAGE 10 0.0001
945 VAGINAL HAEMORRHAGE 4 0.0001
946 BLOOD CREATININE INCREASED 6 0.0001
947 PSORIASIS 12 0.0001
948 OSTEONECROSIS 3 0.0001
949 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
950 STAPHYLOCOCCAL INFECTION 3 0.0001
951 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
952 EXPIRED PRODUCT ADMINISTERED 3 0.0001
953 HYPERKALAEMIA 3 0.0001
954 CARDIAC ARREST 7 0.0001
955 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
956 WHEEZING 5 0.0001
957 THROMBOCYTOPENIA 9 0.0001
958 BLOOD GLUCOSE INCREASED 15 0.0001
959 CARDIOVASCULAR DISORDER 2 0.0001
960 HOSPITALISATION 12 0.0001
961 CARDIO-RESPIRATORY ARREST 3 0.0001
962 PANCYTOPENIA 4 0.0001
963 OVERDOSE 15 0.0001
964 INTENTIONAL PRODUCT MISUSE 6 0.0001
965 BLADDER CANCER 4 0.0001
966 EMOTIONAL DISTRESS 8 0.0001
967 SKIN IRRITATION 3 0.0001
968 BLOOD GLUCOSE DECREASED 3 0.0001
969 INTENTIONAL OVERDOSE 4 0.0001
970 INJECTION SITE REACTION 4 0.0001
971 DEVICE MALFUNCTION 4 0.0001
972 RASH PRURITIC 3 0.0001
973 CHRONIC KIDNEY DISEASE 4 0.0001
974 CARDIAC FAILURE CONGESTIVE 4 0.0000
975 THERAPEUTIC RESPONSE DECREASED 3 0.0000
976 STOMATITIS 3 0.0000
977 DEVICE DIFFICULT TO USE 3 0.0000
978 NO ADVERSE EVENT 7 0.0000
979 INJECTION SITE BRUISING 3 0.0000
980 ANAPHYLACTIC REACTION 2 0.0000
981 COMPLETED SUICIDE 3 0.0000
982 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
983 ACUTE KIDNEY INJURY 5 0.0000
984 RENAL FAILURE 4 0.0000
985 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
986 RHEUMATOID ARTHRITIS 3 0.0000
987 DRUG DEPENDENCE 3 0.0000
988 INJECTION SITE PAIN 3 0.0000